)
Edge17 Oct 2025
A Castle in the Sky: The Story of Oracle
Oracle's journey from database innovator to disciplined enterprise backbone, now shaping the AI buildout with a standardized cloud infrastructure.
Coherus BioSciences (CHRS) investor relations material
Coherus BioSciences UBS Virtual Oncology Day summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.UBS Virtual Oncology Day summary1 Oct, 2025
Strategic overview and pipeline
Focused on improving cancer patient survival with a three-part strategy: marketed drugs, pipeline development, and strategic partnerships.
Lead assets include LOQTORZI (PD-1 inhibitor), CHS-114 (anti-CCR8 antibody), and casdozokitug (anti-IL-27 antibody).
Key data readouts expected around mid-2026 for multiple tumor types, including head and neck, gastric, esophageal, and colorectal cancers.
Actively seeking ex-US partners for pipeline validation and cost-sharing.
Strong financial track record with growth in sales, balance sheet management, and deal revenue.
LOQTORZI (PD-1 inhibitor) insights
LOQTORZI shows over tenfold higher binding affinity than other PD-1s and unique epitope binding, leading to increased activity.
Demonstrates similar efficacy in both PD-L1 high and low patients, differentiating it from competitors.
Approved in frontline and second-line nasopharyngeal carcinoma, with preferred NCCN guideline positioning.
Projected to reach $150–200 million peak sales by mid-2028, with 10–15% quarterly growth expected.
Combination strategy leverages partnerships and internal pipeline assets to expand indications and revenue.
Combination and expansion strategies
Collaborative approach allows LOQTORZI to be included in partner clinical trials, gaining new labels at low cost.
Internal pipeline assets (CHS-114, casdozokitug) are being developed in combination with LOQTORZI.
Demonstrated combinability with chemotherapy, IO agents, and ADCs; phase III data in bladder cancer to be presented.
What is the strategic impact of LOQTORZI's collaborative label expansion?
How does CHS-114's selectivity position it as best-in-class?
How will the current HCC study confirm casdozo's contribution?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Coherus BioSciences earnings date
Q3 20255 Nov, 2025
Next Coherus BioSciences earnings date
Q3 20255 Nov, 2025
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Company Research17 Oct 2025
Beneath the Surface: A Conversation with Epiroc CEO Helena Hedblom
Legacy, innovation, and leading one of Sweden's most influential industrial companies into a new era.
)
Investor Relations14 Oct 2025
Boost Your Earnings Season Strategy With Real‑Time Alerts
Quartr Pro provides real time alerts, trend analysis and live coverage, giving analysts and investors instant insights to act faster in earnings.
Frequently asked questions
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company seeks to create rationally designed molecules for important therapeutic targets that have been the targets of drugs or biological products that are either currently approved or in clinical development for inflammatory, metabolic, autoimmune/lupus, nephrology and cardiovascular/vascular diseases. Coherus BioSciences was founded in 2010 and is headquartered in Redwood City, California.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage